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Golgins are an abundant class of peripheral membrane proteins of the Golgi.
These very long (50–400 nm) rod-like proteins initially capture cognate trans-
port vesicles, thus enabling subsequent SNARE-mediated membrane fusion.
Here, we explore the hypothesis that in addition to serving as vesicle tethers,
Golgins may also possess the capacity to phase separate and, thereby, con-
tribute to the internal organization of the Golgi. GM130 is the most abun-
dant Golgin at the cis Golgi. Remarkably, overexpressed GM130 forms
liquid droplets in cells analogous to those described for numerous intrinsically
disordered proteins with low complexity sequences, even though GM130 is
neither low in complexity nor intrinsically disordered. Virtually pure recombi-
nant GM130 also phase-separates into dynamic, liquid-like droplets in close
to physiological buffers and at concentrations similar to its estimated local
concentration at the cis Golgi.
Keywords: coiled-coil; Golgi matrix; Golgin; liquid; liquid phase
separation
The Golgi has long been an object of fascination for
cell biologists and still holds many mysteries. Discov-
ered in the late 19th century by Camillo Golgi as a
portion of the cell that occasionally took up heavy
metal stains, it provided a useful anatomical tool. Over
the ensuing decades, the ‘Golgi body’ was found by
cytologists in many non-neuronal cells, especially in
glandular cells that produce secretions, and it was
gradually recognized to have a likely role in this pro-
cess, and the term ‘body’ evolved to become ‘appara-
tus’. With the advent of biological electron microscopy
beginning in the 1940s, its ultrastructure proved to be
both universal and remarkable: ~ 1-µm-diameter
stacks of 4–6 flattened, pancake-like membrane-bound
cisternae surrounded by a swarm of what we now
recognize to be 50- to 100-nm-diameter transport vesi-
cles. The key role of the Golgi apparatus in secretion
was firmly established in the 1960s when George
Palade and colleagues traced secreted proteins as they
traveled from synthesis by ribosomes bound to the ER
to the Golgi before reaching secretory storage vesicles
[1].
Many secretions contain complex carbohydrates,
and most of these sugar residues are added during pas-
sage through the Golgi apparatus. The glycosyltrans-
ferases catalyzing the successive steps are strategically
located in successive cisternae of the stack: Inner sug-
ars in the structure are added mainly at the entry face
(termed ‘cis’) of the stack; sugars in the middle being
added mainly in middle (‘medial’) cisternae; and
Abbreviations
FRAP, fluorescence recovery after photobleaching; IDR, intrinsically disordered regions.
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outermost sugars are mainly added at the opposite
(‘trans’) end [2]. The cargoes then depart from this end
after packaging into separate membrane-bounded car-
riers, sorted according to their ultimate destination
(plasma membrane, lysosome, secretory storage vesicle,
etc.).
With the development of GFP-tagging in the 1990s
[3], it became apparent that the Golgi is a highly
dynamic structure within which the glycosyltrans-
ferases and other membrane proteins—though steady-
state residents—are highly mobile [4]. Likewise, the
peripheral membrane components of the Golgi con-
stantly exchange with cytoplasmic pools [4]. The Golgi
extensively fragments prior to cell division, triggered
by mitotic phosphorylation, and these fragments of
the cisternae re-assemble in minutes upon de-phospho-
rylation within each daughter cell [2,5]. Two classes of
drugs acting via distinct mechanisms each rapidly dis-
assemble the Golgi, which then spontaneously reap-
pears as rapidly when the drug is washed out [6,7].
The basis of this remarkable plasticity of this orga-
nelle is a long-standing mystery. How can we account
for this dramatic elasticity of this asymmetric struc-
ture? An attractive explanation, which we have sug-
gested elsewhere [8], arises from a series of recent
discoveries concerning the basis of similar plasticity
among so-called membrane-less organelles, a category
that includes RNA-containing structures such as P
granules, P bodies, cytoplasmic stress granules, and
the nucleolus [9–12], which are now recognized to arise
spontaneously by phase separations. Liquid–liquid
phase separation of their RNA and intrinsically disor-
dered protein components from cytoplasm (or nucleo-
plasm) occurs on the basis of numerous low-affinity
mutual interactions that afford each such condensate
internal fluidity, a spherical shape, and importantly
compositional specificity that is maintained in the
steady state in the face of rapid exchange between the
condensate and its surrounding medium [13].
If the Golgi were a liquid-like condensate of cytosol-
derived proteins phase-separating with membranes
(rather than nucleic acids), what could be the identity of
these proteins? We have suggested [8] that they may be a
class of abundant cytoplasmically derived proteins ter-
med ‘Golgins’ [14] because these proteins are known to
bind Golgi membranes and have similar physical–chem-
ical properties, all being helical bundle-based rods, and
because they are located differentially along the cis-trans
axis. This latter feature could, in theory, enable internal
phase separation to yield Golgi subcompartments, anal-
ogous to what has been found for the nucleolus [15].
Golgins are known to function as vesicle ‘tethers’,
which initially capture transport vesicles at each level of
the Golgi [14]. Here, we explore the hypothesis that, in
addition to this well-established function, Golgins may
possess the capacity to phase-separate and in so doing
also contribute to the internal, dynamic organization of
the Golgi stack. We focused on the most abundant Gol-
gin of the Golgi stack, GM130 [16], which is localized at
the cis face [17]. Recent quantitative proteomics by mass
spectroscopy indicated that the number of copies of this
Golgin in each HeLa cell (about 300 000) exceeds the
quantity of its known Golgi anchor (GRASP65) by
about 14-fold [16]. We have independently confirmed
this by quantitative western blotting (Fig. S1A,B). This
raised the interesting possibility that the majority of
GM130 could be anchored to the cis face of the Golgi
indirectly by condensing with the relatively rare copies
that are directly bound to the surface.
Materials and methods
Cloning of pCMV-mEGFP-GM130-FLAG
The mEGFP-GM130-FLAG construct was prepared by
PCR amplification of GM130-FLAG from a Myc-DDK-
tagged cDNA clone of human GM130 (Origene,
RC209641, Rockville, MD, USA) using the forward primer
CTCAAGCTTCGAATTCTGGTAGTCTGGAAGTTCTG
TTCCAGGGGCCGC
TGATGTGGCCCCAACCCCGCCTCC and the reverse
primer GTCGACTGCAGAATTAAAC
CTTATCGTCGTCATCCTTGTAATCCAGGATATCA.
The amplification product was purified using the QIAquick
gel-extraction kit (Qiagen, 28704, Hilden, Germany) and sub-
cloned into an EcoRI-digested (NEB, R3101S) mEGFP mam-
malian expression vector (Addgene plasmid #54759, gift from
Michael Davidson) using In-Fusion Cloning (Takara Bio,
638910, Kusatsu, Japan).
Cell culture, transfection, and labeling
HeLa cells (ATCC, CCL-2, Old Town Manassas, VA, USA)
were grown at 37° C and 5% CO2 in Dulbecco’s modified
Eagle’s medium (Thermo Fisher Scientific, Waltham, MA,
USA) supplemented with 10% FBS (Thermo Fisher Scien-
tific). 106 cells were electroporated with 4 µg GFP-GM130
using Nucleofector Kit R (Lonza, VVCA-1001, Basel,
Switzerland) and program I-13 on a Nucleofector 2b device
(Lonza, AAB-1001). Cells were seeded on a glass-bottom
dish (MatTek, P35G-1.5-14-C, Ashland, MA, USA) coated
with fibronectin (Millipore, FC010, Burlington, MA, USA)
for live-cell imaging, or on fibronectin-coated coverglass
(Electron Microscopy Sciences #1.5, 12 mm), and fixed by
incubating 15 min with 4% para-formaldehyde. Fixed cells
were washed with PBS and permeabilized with permeabiliza-
tion buffer (0.05% Triton X-100, 0.3% IGEPAL CA-630,
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0.1% BSA in PBS) for 3 min, then washed with wash buffer
(0.05% Triton X-100, 0.05% Igepal CA-630, 0.2% BSA in
PBS), and blocked 1 h in blocking buffer (0.05% Triton X-
100, 0.05% Igepal CA-630, 5% normal goat serum) at room
temperature. Cells were labeled with anti-GM130 (BD,
610823, Franklin Lakes, NJ, USA) for 1 h, washed and
labeled with Alexa Fluor 647 secondary antibody (Thermo
Fisher Scientific, A-21236), and washed and then mounted in
prolong gold (Invitrogen, P36930, Carlsbad, CA, USA).
Cells were imaged on a Zeiss (Oberkochen, Germany) LSM
880 Airyscan confocal microscope.
Fluorescence recovery after photobleaching
(FRAP) protocol and analysis
HeLa cells were grown and transfected with mEGFP-
GM130-FLAG as described above. FRAP experiments
were performed on a Zeiss LSM 880 Airyscan confocal
microscope, using a Plan-Apochromat 639 Oil objective
(numerical aperture = 1.4) and an acquisition rate of 2.5
frames per second. Fluorescence photobleaching and
recovery were conducted using kex = 488 nm and
kem = 500–580 nm, with one scan at 100% laser power
for bleaching, and by monitoring recovery at 2% of the
maximum excitation laser power. Recovery curves were
fitted as previously described [18], using Wolfram Mathe-
matica, and by setting the last bleaching frame as t = 0 of
the fluorescence recovery curve.
Protein purification from Expi293 cells
The mEGFP-GM130-FLAG plasmid was transfected into
Expi293 cells (Thermo Fisher) at 1 µgmL1 culture, employ-
ing poly(ethylenimine) (µL) : DNA (µg) ratio of 3 : 1; 6 h
post-transfection, growth enhancers were added according to
the instructions of the manufacturer. After 48 h, the cells were
pelleted at 500 g for 15 min and washed with PBS. Typically,
a pellet stemming from a 150 mL culture was resuspended in
15 mL buffer 1 [50 mM HEPES/KOH pH 7.3, 175 mM NaCl,
5 mM EDTA, 1 mM PMSF, 1 mM TCEP, protease inhibitor
tablet (Roche, Basel, Switzerland)]. Next, 0.33% Triton X-100
(v/v) was added and the lysate rotated at room temperature for
20 min. After adding buffer 1–50 mL and another 20 min of
incubation, unlysed material was pelleted at 16 500 g for
15 min at 12 °C. Next, 4.5-mL anti-FLAG affinity resin was
washed with 20 mL buffer 1, followed by a wash with 10 mL
buffer 1 containing 0.1% (v/v) Triton X-100. Next, the lysate
was added to the washed beads and incubated for 3 h at room
temperature. The suspension was settled on a column and
drained, and washed with 10 mL buffer 1. Next, the beads
were washed with 50 mL buffer 2 (buffer 1 plus 1 mM ATP,
1 mM MgCl2). Recombinant GM130 was eluted from the
beads in buffer 3 (buffer 1 plus 230 ngmL1 FLAG peptide),
35 min per elution, six fractions total. Immediately after elu-
tion, the fractions were spun at 10 000 g for 6 min and the
supernatant desalted on G25-Sephadex (Thermo Fisher, NAP-
5) columns equilibrated with 5 mM HEPES/KOH pH 7.3. The
concentration of recombinant mGFP-GM130-FLAG was
determined by quantitative western blotting employing a
recombinant GFP standard with known concentration
(Abcam, Cambridge, UK). To determine the concentration of
GM130 in cells, recombinant GFP-GM130-FLAG was blotted
at increasing (known) protein amounts and compared to
lysates of increasing amounts of EXPI293F cells that were sub-
jected to automated cell counting (Bio-Rad, TC20, Hercules,
CA, USA). Statistical analysis was performed using GRAPHPAD
PRISM 6 (GraphPad Software, San Diego, CA, USA) for
unpaired, two-tailed t-tests. Differences were considered
significant if P-value < 0.05(∗), <0.01(∗∗), or < 0.001(∗∗∗).
Concentration measurements of phase-separated
GM130 using fluorescence intensity
The sample of purified mEGFP-GM130-FLAG was pipet-
ted onto a glass-bottom dish (MatTek, P35G-1.5-14-C) and
imaged using a Zeiss LSM 710 Duo confocal microscope,
with the experimental conditions held constant across mea-
surements. The acquired images were quantified using IM-
AGEJ (NIH, Bethesda, MD, USA) by calculating the mean
and standard deviation of pixel intensity within a region of
interest [19]. ROIs for individual GM130 condensates were
obtained using the Analyze Particles Tool in IMAGEJ, yield-
ing distinct intensity and size measurements for several
hundred condensates. Importantly, the mean pixel intensity
was found to be independent of condensate size for diame-
ters > 500 nm, consistent with their large size relative to
the confocal volume. Smaller condensates were not
included in the subsequent analysis because their intensity
is expected to depend on their location relative to the con-
focal volume. The calibration curve relating the pixel inten-
sity to fluorophore concentration was obtained by imaging
recombinant 6xHis-mEGFP-FLAG solutions of different
known concentrations. Fluorescence intensity in the cali-
bration images was found to depend on the distance of the
imaging plane from the glass surface. In order to account
for this systematic error, calibration images were acquired
at ten evenly spaced heights ranging 0–30 µm from the
glass surface, and their mean pixel intensities averaged. The
resultant intensities were plotted as a function of mEGFP
concentration and fitted with a linear function using Wol-
fram Mathematica, taking into account the uncertainties
stemming from variations between individual measurements
and the systematic error arising from the height depen-
dence. Using this calibration curve, the mean pixel intensi-
ties of GM130 condensates were converted to
concentrations. The measurement uncertainties were calcu-
lated from intensity variations between individual conden-
sates and the previously determined uncertainty of the best-
fit calibration curve. Similarly, the critical concentration for
GM130 phase separation was obtained by drawing ROIs
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around phase transition events and measuring their pixel
intensities immediately prior to the transition event.
Results and Discussion
Overexpressed GM130 forms liquid-like droplets
in cells
One hallmark of an intrinsically disordered protein
that forms or contributes to membrane-less organelles
is its individual capacity to phase-separate into
micron-scale condensates when overexpressed in cells.
Typically, these condensates are spherical at first and
are referred to as ‘droplets’ because of their dynamic
behavior. Their constituents diffuse within a droplet;
they exchange among droplets, and the droplets them-
selves coalesce by fusion over time. Although the dro-
plets behave as liquids at the outset, over minutes to
hours they typically ‘harden’ as the condensed protein
molecules form increasingly static, solid-like arrange-
ments. This becomes evident as the condensates gradu-
ally assume nonplastic, irregular shapes and the other
liquid-like properties diminish [20].
The Golgin GM130 is a homo-tetramer of ~ 130 kD
subunits consisting of four parallel coiled-coil segments
with interspersed flexible linkers, and with short non-
helical regions at both its amino and carboxyl-terminal
ends (Fig. 1A). When fully extended, GM130 can
potentially extend to ~ 100 nm [21]. A GFP-tagged
version of GM130 (also containing a FLAG epitope
tag for subsequent purification) was overexpressed
in HeLa cells and studied by confocal microscopy
(Fig. 1B). Surprisingly, because GM130 lacks abun-
dant low complexity sequences and is not intrinsically
disordered, condensates form, and these occur mainly
in the nucleus. GM130 contains a nuclear localization
signal near its amino-terminus [22]. Ordinarily, this
signal is blocked by binding to another Golgi-related
protein p115 [22], but when GM130 is overexpressed
and exceeds its partner, the excess unbound GM130 is
expected to be taken up by the nucleus.
The abundance, size, and properties of the GM130
condensates evolved over time. At 3 h post-transfec-
tion, GM130 had already accumulated in the
nucleus, forming a ‘haze’ of uncondensed protein
interspersed with condensed, punctate structures
(Fig. 1B). Over the course of the next hour, the
background haze gradually diminished as the size of
the condensates grew. By 4 h, the vast majority of
nuclear GM130 had assembled into apparently spher-
ical, droplet-like structures ~ 1 µm in diameter. These
spherical condensates continued to grow in size up
to ~ 2 µm in diameter over the next several hours
and increasingly became nonspherical, suggestive of
hardening.
The simplest interpretation is that free GM130 tetra-
mers are transported across nuclear pores into the
nucleoplasm, forming the background haze. Over time,
the concentration of GM130 in the nucleus progres-
sively increases, and when it saturates, the separate
droplet phase begins to form. Additional GM130 then
accrues to the droplets, which grow correspondingly in
size. The droplets not only grow in size, but also
become reduced in number (compare, e.g., 8 h with
4 h in Fig. 1B) as they coalesce by fusion, which will
be studied in detail below.
How relevant is the formation of the nuclear conden-
sates of overexpressed GM130 to the physiological
mechanism of association of endogenous GM130 in the
Golgi? The fact that the condensates of overexpressed
GM130 accumulate inside the nucleus, while the Golgi
itself remains outside the nucleus creates a fortuitous
opportunity to answer this question, using a form of
the classic competitive binding experiment in which the
distribution of a common ligand across a dialysis mem-
brane between two partners measures their relative
affinity for the ligand [23]. Here, the nuclear envelope
plays the role of the dialysis bag, and the GM130 tetra-
mer is the ligand, partitioning across the membrane
between Golgi and condensates. If the endogenous
Golgi complement of GM130 re-distributes to the
nuclear condensates, then the energetic environment
associating them to condensates must be similar or even
more favorable than that retaining it in the Golgi.
To test this, we transfected HeLa cells with GFP-
GM130 for 3–6 h before the cells were fixed and
stained with anti-GM130 antibodies to equally reveal
the total of both expressed exogenous and endogenous
GM130 (anti-GM130), or by imaging GFP fluores-
cence to selectively reveal the exogenous population
(Fig. 1C). In cells with low exogenous GFP-GM130
expression levels i), the majority of the total GM130
remained localized to the Golgi, while the exogenous
GM130 localized to Golgi but also accumulated in the
nucleus, mainly as the background ‘haze’ of apparently
unassembled tetramers. At intermediate expression
levels ii), the exogenous GM130 population is mainly
in the nucleus and droplets containing exogenous
GM130 begin to appear in the nucleus. At high
expression levels iii), the majority of the total (exoge-
nous plus endogenous) GM130 mainly resides in
spherical droplets within the nucleus; little GM130
remains at the Golgi. The proportion of total GM130
in the Golgi decreases continuously as a function of
increasing GFP-GM130 expression levels (Fig. 1D).
This depletion of GM130 from the Golgi area by
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relocation results in Golgi fragmentation (as judged
from immunolabeling of the cis Golgi resident and
membrane-integral protein GPP130 [24]; Fig. S1C),
corresponding to the phenotype when endogenous
GM130 is knocked down with siRNA [25]. Note that
the spherical GM130 nuclear condensates revealed by
Prebleach Bleach Postbleach
Prebleach Bleach Postbleach
A
B
C D
Fig. 2. Phase-separated GM130
condensates in the nucleus are dynamic.
(A) Live-cell confocal microscopy of a
fusion event (white arrows) between two
nuclear mEGFP-GM130-FLAG
condensates. (B) Representative FRAP of
small (upper panel) and large (lower panel)
mEGFP-GM130-FLAG nuclear
condensates imaged 2–5 h post-
transfection. (C) Representative rate of
recovery of small (magenta) and large
(green) nuclear mEGFP-GM130-FLAG
condensates. (D) Mobile fraction (%
recovery) of nuclear mEGFP-GM130-FLAG
droplets is plotted as a function of their
size. Highlighted data points correspond to
images shown in (C). Scale bars: 1 µm.
Fig. 1. GM130 forms condensates in the nucleus. (A) Tetrameric structure of recombinant mEGFP-GM130-FLAG obtained by computational
modeling. The C-terminal FLAG tag was used for affinity purification in subsequent experiments (see main text). (B) Upper left: localization
of endogenous GM130 (immunofluorescence: green; nucleus: blue). Gallery: time-lapse confocal imaging of a single representative HeLa
cell transfected with mEGFP-GM130-FLAG. (C) mEGFP-GM130-FLAG-transfected HeLa cells were fixed 3–6 h post-transfection and imaged
for total GM130 (anti-GM130 immunofluorescence) and exogenous GM130 (GFP fluorescence). i), ii), and iii) represent cells with low,
medium, and high mEGFP-GM130-FLAG expression levels, respectively (max. intensity projections of Z-stacks). (D) The ratio of total GM130
in the Golgi (G) versus the nucleus (N) was plotted as a function of GFP signal in the nucleus. Scale bars: 5 µm.
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GFP typically have only their outer surfaces stained
by anti-GM130 antibodies, giving them a ring-like
appearance (Fig. 1C, iii). This suggests that the anti-
bodies could not fully penetrate the condensates after
fixation and permeabilization of the cells.
Our results so far indicate that excess GM130 is
transported into the nucleus to form spherical conden-
sates that are apparently liquid-like on the basis of
their shape. These droplets must create an energetically
similar microenvironment to that experienced by
endogenous GM130 as it resides in the cis Golgi,
because the endogenous Golgin can favorably join
these droplets when they are present in excess.
To directly assess fluidity, we looked for fusion
among droplets and internal diffusion of their con-
stituents, the current standard in the field [26]. At 3 h
post-transfection, when the droplets are prominent and
still primarily spherical, we observed fusion events in
which spherical droplets coalesced and relaxed back
into a combined spherical shape within a few seconds
(Fig. 2A). We investigated the mobility of GM130
within the droplets by performing fluorescence recov-
ery after photobleaching (FRAP) experiments on indi-
vidual nuclear condensates (Fig 2B,C). Smaller and
presumably younger condensates (< 1 µm diameter)
exhibited a faster rate of recovery and a greater mobile
fraction than the larger and presumably older conden-
sates (> 1 µm diameter). In fact, we observed an
almost linear relationship between the size of GM130
nuclear droplets and their mobile fractions, with the
mobile fraction dropping below 50% for droplets
exceeding 1 µm in diameter (Fig. 2D).
Purified GM130 phase-separates into dynamic,
liquid-like droplets
To test for possible phase separation of GM130
in vitro, we established a protocol enabling the reliable
and reproducible purification of native mEGFP-tagged
GM130 expressed in Expi293F cells whose purity
exceeded 95% as determined by quantitative SDS/
PAGE and western blotting (Fig. 3). We then vali-
dated an assay [27] (Fig. 4A) to test for phase separa-
tion of these recombinant proteins. A 5–10 µL drop
of buffered protein solution was deposited on an
exposed microscope slide and allowed to evaporate,
thereby inducing advective flows that gradually con-
centrated the protein near the rim of the drop in what
is termed the coffee ring effect [28] (Fig. 4B). These
flows arise because the contact line, at which the drop
surface meets the microscope slide, is held in place or
‘pinned’ by surface roughness and chemical hetero-
geneities in the glass substrate. Consequently, whereas
the evaporative loss near the drop center will merely
decrease the drop height, evaporated fluid near the
contact line must be replenished by an outward flow
of fluid (Video S1). We monitored this process using
confocal microscopy of mEGFP fluorescence and
found that over the course of 10–20 min of evapora-
tion, the local protein concentration at the rim
increased (Fig. 4C), in agreement with numerical mod-
eling (Appendix S1). As negative controls, neither
recombinant purified mEGFP alone (nor a number of
other control proteins) condensed under the same con-
ditions (Fig. 4C lower panel and Fig. S2), whereas a
well-characterized phase-separating protein, the disor-
dered N terminus of Ddx4 [29], did condense
(Fig. 4C, upper panel). These results establish the abil-
ity of our assay to faithfully probe phase separations.
Samples containing 10–100 nM GM130 were then
tested at 37 °C. As the local concentration of GM130
increases near the rim of the sample, the protein spon-
taneously condenses (Fig. 5A) into a multitude of µm-
sized droplets (region 1) and at even higher concentra-
tions into an inverted phase in which the GM130-rich
phase is continuous and hosts aqueous droplets
depleted in GM130 (region 2). This morphology is in
agreement with theoretical predictions for phase sepa-
ration in concentration gradients [30]. Importantly,
the droplets appear within 1 s and all at once, indica-
tive of crossing a phase transition boundary (compare
Fig. 5A, 15 and 20 min, and Video S2 at time 914 s).
The droplet assay further revealed that purified
mCherry-tagged fragments of GM130, several of
which were predicted to form coiled-coils in their
entirety [31], could also undergo phase separation,
albeit to different extents (Fig. S3). Importantly,
Fig. 3. Purity of recombinant mEGFP-GM130-FLAG. SDS/PAGE of
purified mEGFP-GM130-FLAG stained with Coomassie (left), and
the accompanying western blots using anti-GFP (middle) and anti-
FLAG (right) antibodies.
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concerning the above experiments we generally
employed conditions approximating the cytoplasm
(20 mM HEPES/KOH, pH 7.3, 140 mM KCl, 1 mM
MgCl2, 1 mM DTT) and notably did not add any
crowding agent (such as a polyethylene glycol) needed
in many other cases to observe condensate formation
in vitro [26,32,33]. The droplet evaporation assay
yielded similar results even with a simplified buffer
composition (5 mM HEPES/KOH, pH 7.3, 140 mM
KCl), thereby ruling out that phase separation is
induced by increased concentrations of buffer compo-
nents at the rim. In subsequent experiments, we there-
fore employed the simplified system to minimize the
concentration gradients arising from the various buffer
components during evaporation. To be certain that
the condensates were not due to excessive local con-
centrations of salts in regions 1 and 2, we represent
the droplet evaporation assay with initial [KCl] in the
range from 0 to 500 mM with qualitatively similar
results across the entire range (Fig. S4).
As observed for the spherical droplets of GM130 in
the nucleus, both the droplets rich in GM130 in region
1 and the aqueous droplets hosted by the continuous
GM130 phase in region 2 coalesced via fusion and
relaxed back to into spherical shapes thereafter
(Fig. 5B). We investigated the mobility of GM130 in
individual droplets and the continuous phase using
FRAP experiments (Fig. 5C,D). The individual
Fig. 4. Illustration and validation of the evaporation assay. (A) Illustration depicting confocal fluorescence imaging of a drop of mEGFP-
GM130-FLAG solution during evaporation. The protein accumulates at the rim of the drop due to the coffee ring effect, forming a
concentration gradient that increases over time. In all experiments, a focal plane 3 µm above the glass slide was chosen to minimize
fluorescence background. (B) Illustration of the coffee ring effect in an evaporating drop of protein solution with pinned contact line to the
glass slide. Evaporated fluid near the contact line must be replenished and by an outward flow of solution from the interior, thereby
concentrating the protein near the rim of the drop. (C) Time-lapse of accumulation of protein at the edge of the protein solution during
evaporation. Upon evaporation, Alexa Fluor 647-labeled recombinant N-terminal domain of Ddx4 (residues 1–236) (5 mM HEPES/KOH pH
7.3, 120 mM KCl, and 1 mM TCEP and at 37 °C) forms spherical condensates (top panel), whereas recombinant 6xHis-mEGFP-FLAG (20 mM
HEPES/KOH pH 7.3, 140 mM KCl, 1 mM MgCl2, 1 mM DTT, and at 37 °C) forms a smooth concentration gradient (bottom panel). The
dashed arrow points along the gradient of increasing protein concentration, from the center of the evaporating sample toward its rim. Scale
bars: 20 µm.
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AB
C
D
Fig. 5. Purified GM130 phase-separates
into liquid-like condensates in vitro. (A)
Time-lapse of accumulation of mEGFP
fluorescence at the edge of the protein
solution during evaporation (20 mM
HEPES/KOH pH 7.3, 140 mM KCl, 1 mM
MgCl2, 1 mM DTT, and at 37 °C). Upon
evaporation, recombinant mEGFP-GM130-
FLAG forms a gradient and then becomes
supersaturated at around 20 min,
undergoing liquid–liquid phase separation.
At intermediate concentration (Region 1),
mEGFP-GM130-FLAG phase-separates
into spherical condensates whereas at
high concentration (Region 2), it forms a
continuous dense phase containing
fenestrations of dilute phase where
protein is depleted. (B) Time series
showing fusion between two condensates
(Region 1) or two fenestrations (Region 2).
White arrows indicate individual fusion
events. Line scans indicate fluorescence
intensity along the dotted white line for
each frame. Scale bars: 5 µm. (C)
Representative FRAP of a spherical
condensate (upper panel) and the
continuous phase (lower panel) of phase-
separated mEGFP-GM130-FLAG. Scale
bars: 1 µm. (D) FRAP curves of the
spherical condensate (solid) and the
continuous phase (dashed) shown in (C).
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droplets and the continuous phase of GM130 both
exhibited fluorescence recovery within seconds of
photobleaching.
In order to determine the local concentration of
GM130 within the two forms of condensed GM130
phases, we measured the mean fluorescence intensity
of recombinant GFP under the same experimental
conditions and obtained a calibration curve (Fig. 6A).
This calibration curve was linear over the whole range
of intensities measured for GM130. Furthermore,
because evaporation at the rim concentrates salt ions
along with protein, we wanted to rule out that the
observed phase separation was simply a result of the
protein salting out by showing that the measured con-
centrations did not depend on the initial salt concen-
tration in the buffer. We therefore varied the starting
KCl concentration in the droplet from 0 to 500 mM
and quantified the concentration of GM130 in the
resultant condensates (Fig. 6B).
The concentration of GM130 in the droplets (region
1) was 150  20 µM independent of [KCl] above
~ 100 mM and somewhat higher (170  20 µM) at 0–
100 mM KCl. In the continuous dense phase (region
2), the concentration of GM130 was 230  30 µM
independent of [KCl] above ~ 100 mM and marginally
lower (200  30 µM) at lower [KCl]. Although the
GM130 concentration in the condensed droplet phases
was largely independent of salt concentration and tem-
perature, the size distribution of the droplets strongly
depended on these variables (Fig. S4). These data
therefore confirm that phase separation in the evapora-
tion assay is not a result of salting out of the protein,
but an intrinsic feature of the GM130.
Possible implications for organization of the
Golgi
Our results indicate that the Golgin GM130 indeed
has the intrinsic capacity to phase separate into liquid-
like condensates. Liquid–liquid phase separations of
polymers, including proteins, rely either on stochastic
combinations of a large number of very low-affinity
intermolecular interactions among small clusters of
side chains in the case of intrinsically disordered
regions (IDR) of extensive low complexity sequence-
containing proteins [11,29,34,35]; or on multivalent
moderate affinity interactions among folded scaffold-
ing domains (such as with SH3 and SH2 domain-con-
taining proteins [36,37]). Because GM130 contains
neither such sequences nor such domains, the molecu-
lar mechanism that allows for weak collective interac-
tions among GM130 tetramers is unclear. Since most
of the surface of GM130 (Fig. 1A) consists of helical
bundles, it seems most likely that weak interactions
involving these surfaces are critical determinants. The
fact that phase separation occurs in the 50–100 µM
Fig. 6. Concentration measurements of phase-separated GM130
in vitro. (A) mEGFP-GM130-FLAG concentration measurements
shown in (B) fall into a well-calibrated range for the mEGFP standard
curve. Green points denote measurements of mEGFP fluorescence
intensity for solutions of known mEGFP concentrations at 37 °C
in 5 mM HEPES/KOH pH 7.3, 140 mM KCl. Error bars indicate
systematic error in fluorescence intensity measurement due to
variations in microscope optics. The green line is the fitted calibration
curve. Black and gray points denote fluorescence intensity
measurements of mEGFP-GM130-FLAG condensates and the
continuous dense phase, respectively. Vertical error bars stem from
variability between individual fluorescence intensity measurements.
Horizontal error bars represent the standard error in mEGFP-GM130-
FLAG concentration calculated from the uncertainty in the calibration
curve and the variability between individual measurements. (B)
Concentration measurements of mEGFP-GM130-FLAG inside
condensates (solid black circles) and in the continuous dense phase
(open gray circles) for buffers containing 5 mM HEPES and different
initial salt concentrations at the onset of evaporation and at 37 °C.
The concentration values were calculated from mEGFP fluorescence
using the mEGFP calibration curve shown in (A).
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protein concentration range at physiological ionic
strength, pH, and temperature suggests that the under-
lying interactions are in this same range of affinities,
and therefore likely involve individual side chains or
small clusters of them located on the surface of the
rods. This would be broadly analogous to condensates
forming from IDRs and the key differences being that
for GM130, the involved residues would be on the sur-
face of a highly structured and rigid rod and that dif-
ferent side chains may be involved than those driving
IDR condensation.
These in vitro observations seem likely to be relevant
to the physical state of GM130 in the native Golgi
stack for several reasons. First, analogous condensates
can form in cells. Overexpressed GM130 is transported
into the nucleus to form spherical condensates that are
initially dynamic and liquid-like. Second, these dro-
plets evidently provide an environment, which is ener-
getically similar to that experienced by endogenous
GM130 as it resides in the Golgi, because endogenous
GM130 efficiently relocates to join in them. Third, a
straightforward estimate (Fig. S5) of the overall con-
centration of GM130 in the cis Golgi suggests that it
is similar to its concentration within the condensates.
Yet, there must also be significant differences because
the endogenous GM130, though packed at similar
overall density as it is in spherical condensates, is at
least in part organized on the Golgi surface as an ori-
ented monolayer by binding from one end to its pro-
tein receptor, GRASP65. It seems likely that even
within the spherical condensates such lateral registra-
tion occurs locally and intrinsic to the mechanism of
coacervation.
In conclusion, at least one member of the Golgin
family undergoes liquid–liquid phase separation under
conditions that approximate those in the cell. We spec-
ulate that most if not all Golgins and similarly struc-
tured vesicle tethers may also have this capacity. While
there are many sequence similarities among the Gol-
gins, they differ greatly in size. If lateral registration is
an important principle underlying phase separation of
this class of proteins, then length could be part of a
code that enables the spontaneous assembly of
domains within the Golgi having distinct Golgin
compositions [38]. Is the Golgi surface contained by a
protective ‘cocoon’ of two-dimensional Golgin conden-
sates that excludes most cellular constituents (‘zone of
exclusion’ [39,40] but selectively admits vesicles con-
taining the cognate Rab GTPase proteins, much as the
nuclear pore admits its cargo into a hydrogel [34]? It
may even be that the Golgi—including its membranes
—is templated by this cocoon rather than the other
way around.
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Fig. S1. (A) Quantitative western blots of endogenous
GM130 and GRASP65 in Expi293F lysates compared
to standards of their respective purified recombinant
counterparts at known concentrations. (B) Quantita-
tion of the western blots yields ~ 270 000 molecules/
cell for GM130 and ~ 19 000 molecules/cell for
GRASP65. (C) Hela cells were electroporated with
mEGFP-GM130 or left untransfected. 24 h post-
transfection, cells were fixed and immunolabeled with
anti-GPP130 (Biolegend 923801) followed by anti-
rabbit AF647 secondary Ab (Thermo Fisher Scientific
A-21244). Scale bars: 5 µm.
Fig. S2. A number of proteins chosen as negative con-
trols do not phase separate in the evaporation assay.
Fig. S3. Different domains of GM130 exhibit different
capacities to undergo phase separation.
Fig. S4. mEGFP fluorescence micrographs of the dro-
plet evaporation assay showing phase-separated
mEGFP-GM130-FLAG (5 mM HEPES/KOH pH 7.3)
near the rim for various initial [KCl] in the range 0–
500 mM, as indicated, and at either 23 °C (left panel)
or 37 °C (right panel).
Fig. S5. Estimate of the local concentration of GM130
at the cis-Golgi for comparison with data shown in
Fig. 5.
Appendix S1. Concentration Measurements of mEGFP
Near the Rim.
Video S1. Origin of the coffee ring effect in an evapo-
rating drop (blue) on a flat substrate (gray).
Video S2. Fluorescence confocal microscopy of recom-
binant mEGFP-GM130-FLAG in the droplet evapora-
tion assay (20 mM HEPES/KOH pH 7.3, 140 mM
KCl, 1 mM MgCl2, 1 mM DTT, and at 37° C).
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